Characterization of T Antigens, Including Middle T and Alternative T, Expressed by the Human Polyomavirus Associated with Trichodysplasia Spinulosa
The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia...
Saved in:
Published in | Journal of virology Vol. 89; no. 18; pp. 9427 - 9439 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.09.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia spinulosa-associated polyomavirus (TSPyV) has not been established yet, hampering further study of its pathogenic mechanisms and taxonomic relationship. Here, we characterized TSPyV T antigen expression in human cell lines transfected with the TSPyV early region. Sequencing of T antigen-encoded reverse transcription-PCR (RT-PCR) products revealed three splice donor and acceptor sites creating six mRNA splice products that potentially encode the antigens small T (ST), middle T (MT), large T (LT), tiny T, 21kT, and alternative T (ALTO). Except for 21kT, these splice products were also detected in skin of TSPyV-infected patients. At least three splice products were confirmed by Northern blotting, likely encoding LT, MT, ST, 21kT, and ALTO. Protein expression was demonstrated for LT, ALTO, and possibly MT, with LT detected in the nucleus and ALTO in the cytoplasm of transfected cells. Splice site and start codon mutations indicated that ALTO is encoded by the same splice product that encodes LT and uses internal start codons for initiation. The genuineness of ALTO was indicated by the identification of acetylated N-terminal ALTO peptides by mass spectrometry. Summarizing, TSPyV exhibits an expression pattern characterized by both MT and ALTO expression, combining features of rodent and human polyomaviruses. This unique expression pattern provides important leads for further study of polyomavirus-related disease and for an understanding of polyomavirus evolution.
IMPORTANCE
The human trichodysplasia spinulosa-associated polyomavirus (TSPyV) is distinguished among polyomaviruses for combining productive infection with cell-transforming properties. In the research presented here, we further substantiate this unique position by indicating expression of both middle T antigen (MT) and alternative T antigen (ALTO) in TSPyV. So far, none of the human polyomaviruses was shown to express MT, which is considered the most important viral oncoprotein of rodent polyomaviruses. Coexpression of ALTO and MT, which involves a conserved, recently recognized overlapping ORF subject to positive selection, has not been observed before for any polyomavirus. As a result of our findings, this study provides valuable new insights into polyomavirus T gene use and expression. Obviously, these insights will be instrumental in further study and gaining an understanding of TSPyV pathogenicity. More importantly, however, they provide important leads with regard to the interrelationship, functionality, and evolution of polyomaviruses as a whole, indicating that TSPyV is a suitable model virus to study these entities further. |
---|---|
AbstractList | UNLABELLEDThe polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia spinulosa-associated polyomavirus (TSPyV) has not been established yet, hampering further study of its pathogenic mechanisms and taxonomic relationship. Here, we characterized TSPyV T antigen expression in human cell lines transfected with the TSPyV early region. Sequencing of T antigen-encoded reverse transcription-PCR (RT-PCR) products revealed three splice donor and acceptor sites creating six mRNA splice products that potentially encode the antigens small T (ST), middle T (MT), large T (LT), tiny T, 21kT, and alternative T (ALTO). Except for 21kT, these splice products were also detected in skin of TSPyV-infected patients. At least three splice products were confirmed by Northern blotting, likely encoding LT, MT, ST, 21kT, and ALTO. Protein expression was demonstrated for LT, ALTO, and possibly MT, with LT detected in the nucleus and ALTO in the cytoplasm of transfected cells. Splice site and start codon mutations indicated that ALTO is encoded by the same splice product that encodes LT and uses internal start codons for initiation. The genuineness of ALTO was indicated by the identification of acetylated N-terminal ALTO peptides by mass spectrometry. Summarizing, TSPyV exhibits an expression pattern characterized by both MT and ALTO expression, combining features of rodent and human polyomaviruses. This unique expression pattern provides important leads for further study of polyomavirus-related disease and for an understanding of polyomavirus evolution.IMPORTANCEThe human trichodysplasia spinulosa-associated polyomavirus (TSPyV) is distinguished among polyomaviruses for combining productive infection with cell-transforming properties. In the research presented here, we further substantiate this unique position by indicating expression of both middle T antigen (MT) and alternative T antigen (ALTO) in TSPyV. So far, none of the human polyomaviruses was shown to express MT, which is considered the most important viral oncoprotein of rodent polyomaviruses. Coexpression of ALTO and MT, which involves a conserved, recently recognized overlapping ORF subject to positive selection, has not been observed before for any polyomavirus. As a result of our findings, this study provides valuable new insights into polyomavirus T gene use and expression. Obviously, these insights will be instrumental in further study and gaining an understanding of TSPyV pathogenicity. More importantly, however, they provide important leads with regard to the interrelationship, functionality, and evolution of polyomaviruses as a whole, indicating that TSPyV is a suitable model virus to study these entities further. The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia spinulosa-associated polyomavirus (TSPyV) has not been established yet, hampering further study of its pathogenic mechanisms and taxonomic relationship. Here, we characterized TSPyV T antigen expression in human cell lines transfected with the TSPyV early region. Sequencing of T antigen-encoded reverse transcription-PCR (RT-PCR) products revealed three splice donor and acceptor sites creating six mRNA splice products that potentially encode the antigens small T (ST), middle T (MT), large T (LT), tiny T, 21kT, and alternative T (ALTO). Except for 21kT, these splice products were also detected in skin of TSPyV-infected patients. At least three splice products were confirmed by Northern blotting, likely encoding LT, MT, ST, 21kT, and ALTO. Protein expression was demonstrated for LT, ALTO, and possibly MT, with LT detected in the nucleus and ALTO in the cytoplasm of transfected cells. Splice site and start codon mutations indicated that ALTO is encoded by the same splice product that encodes LT and uses internal start codons for initiation. The genuineness of ALTO was indicated by the identification of acetylated N-terminal ALTO peptides by mass spectrometry. Summarizing, TSPyV exhibits an expression pattern characterized by both MT and ALTO expression, combining features of rodent and human polyomaviruses. This unique expression pattern provides important leads for further study of polyomavirus-related disease and for an understanding of polyomavirus evolution. The human trichodysplasia spinulosa-associated polyomavirus (TSPyV) is distinguished among polyomaviruses for combining productive infection with cell-transforming properties. In the research presented here, we further substantiate this unique position by indicating expression of both middle T antigen (MT) and alternative T antigen (ALTO) in TSPyV. So far, none of the human polyomaviruses was shown to express MT, which is considered the most important viral oncoprotein of rodent polyomaviruses. Coexpression of ALTO and MT, which involves a conserved, recently recognized overlapping ORF subject to positive selection, has not been observed before for any polyomavirus. As a result of our findings, this study provides valuable new insights into polyomavirus T gene use and expression. Obviously, these insights will be instrumental in further study and gaining an understanding of TSPyV pathogenicity. More importantly, however, they provide important leads with regard to the interrelationship, functionality, and evolution of polyomaviruses as a whole, indicating that TSPyV is a suitable model virus to study these entities further. The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially overlapping open reading frames (ORFs) located in the early region through alternative mRNA splicing. The T expression pattern of the trichodysplasia spinulosa-associated polyomavirus (TSPyV) has not been established yet, hampering further study of its pathogenic mechanisms and taxonomic relationship. Here, we characterized TSPyV T antigen expression in human cell lines transfected with the TSPyV early region. Sequencing of T antigen-encoded reverse transcription-PCR (RT-PCR) products revealed three splice donor and acceptor sites creating six mRNA splice products that potentially encode the antigens small T (ST), middle T (MT), large T (LT), tiny T, 21kT, and alternative T (ALTO). Except for 21kT, these splice products were also detected in skin of TSPyV-infected patients. At least three splice products were confirmed by Northern blotting, likely encoding LT, MT, ST, 21kT, and ALTO. Protein expression was demonstrated for LT, ALTO, and possibly MT, with LT detected in the nucleus and ALTO in the cytoplasm of transfected cells. Splice site and start codon mutations indicated that ALTO is encoded by the same splice product that encodes LT and uses internal start codons for initiation. The genuineness of ALTO was indicated by the identification of acetylated N-terminal ALTO peptides by mass spectrometry. Summarizing, TSPyV exhibits an expression pattern characterized by both MT and ALTO expression, combining features of rodent and human polyomaviruses. This unique expression pattern provides important leads for further study of polyomavirus-related disease and for an understanding of polyomavirus evolution. IMPORTANCE The human trichodysplasia spinulosa-associated polyomavirus (TSPyV) is distinguished among polyomaviruses for combining productive infection with cell-transforming properties. In the research presented here, we further substantiate this unique position by indicating expression of both middle T antigen (MT) and alternative T antigen (ALTO) in TSPyV. So far, none of the human polyomaviruses was shown to express MT, which is considered the most important viral oncoprotein of rodent polyomaviruses. Coexpression of ALTO and MT, which involves a conserved, recently recognized overlapping ORF subject to positive selection, has not been observed before for any polyomavirus. As a result of our findings, this study provides valuable new insights into polyomavirus T gene use and expression. Obviously, these insights will be instrumental in further study and gaining an understanding of TSPyV pathogenicity. More importantly, however, they provide important leads with regard to the interrelationship, functionality, and evolution of polyomaviruses as a whole, indicating that TSPyV is a suitable model virus to study these entities further. |
Author | Kazem, Siamaque Feltkamp, Mariet C. W. Hensbergen, Paul J. van Vuren, Nick van der Meijden, Els Dargel, Christina A. |
Author_xml | – sequence: 1 givenname: Els surname: van der Meijden fullname: van der Meijden, Els organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 2 givenname: Siamaque surname: Kazem fullname: Kazem, Siamaque organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 3 givenname: Christina A. surname: Dargel fullname: Dargel, Christina A. organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 4 givenname: Nick surname: van Vuren fullname: van Vuren, Nick organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 5 givenname: Paul J. surname: Hensbergen fullname: Hensbergen, Paul J. organization: Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands – sequence: 6 givenname: Mariet C. W. surname: Feltkamp fullname: Feltkamp, Mariet C. W. organization: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26136575$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUFv0zAYhi00xLrBjTPykUMz_Dm221yQqmqwoiGQKIib5ThOY-TYwXYK5W_wh0m3MQHiZMnf877fJz1n6MQHbxB6CuQCgC5fvPm0uSCkAiiAP0AzINWy4BzYCZoRQmnBy-XnU3SW0hdCgDHBHqFTKqAUfMFn6Oe6U1HpbKL9obINHocWb_HKZ7szPs3xxms3Ntbv8FvbNM5MQ-UbvHJTxE-J_fQzx5ffh2hSMg2uDzh3Bl-NvfL4fXCH0Ku9jWPCq5SCtipP0DebO7yNVnehOaTBqWQV_jBYP7qQ1GP0sFUumSd37zn6-Opyu74qrt-93qxX14UulywXUNIWRE11VS4AuOK1MJo1gra8JDUhCiau4u1C1Lw01AC0hhuoFdOCNRUvz9HL295hrHvTaONzVE4O0fYqHmRQVv498baTu7CXjDNasmPB87uCGL6OJmXZ26SNc8qbMCYJCyIoEYIe0Wd_7rpf8tvEBMxvAR1DStG09wgQeRQtJ9HyRrSEI07_wbXNNwKnS637f-gX8ROuNA |
CitedBy_id | crossref_primary_10_1111_tid_12702 crossref_primary_10_3389_fmicb_2022_834368 crossref_primary_10_1002_rmv_2220 crossref_primary_10_1111_jdv_14326 crossref_primary_10_3390_v11100930 crossref_primary_10_1016_j_meegid_2023_105439 crossref_primary_10_1016_j_meegid_2017_06_011 crossref_primary_10_1016_j_vetmic_2017_01_005 crossref_primary_10_1016_j_piel_2017_05_001 crossref_primary_10_1371_journal_ppat_1005574 crossref_primary_10_1099_jgv_0_000714 crossref_primary_10_1371_journal_pone_0244334 crossref_primary_10_1128_JVI_01008_16 crossref_primary_10_1146_annurev_virology_110615_042226 crossref_primary_10_3390_v15112235 crossref_primary_10_3390_v12091014 crossref_primary_10_1099_jgv_0_001467 crossref_primary_10_1177_1178122X17744785 crossref_primary_10_1111_bjd_17592 crossref_primary_10_3390_v8100292 crossref_primary_10_1016_j_virol_2017_03_007 crossref_primary_10_1007_s13205_020_02583_w crossref_primary_10_1073_pnas_2316467120 crossref_primary_10_6061_clinics_2018_e558s crossref_primary_10_7883_yoken_JJID_2019_391 crossref_primary_10_1016_j_jcv_2016_01_001 crossref_primary_10_1111_bjd_14239 crossref_primary_10_1111_tid_13434 crossref_primary_10_1016_j_virol_2015_09_013 crossref_primary_10_1002_jcp_27715 crossref_primary_10_1016_j_jid_2018_09_013 crossref_primary_10_1371_journal_ppat_1009582 crossref_primary_10_3389_fmicb_2018_00398 |
Cites_doi | 10.1002/ijc.29200 10.1016/S0065-230X(10)06001-X 10.1128/MMBR.66.2.179-202.2002 10.1073/pnas.0806526105 10.1128/JVI.01336-09 10.1056/NEJMoa020439 10.1002/j.1460-2075.1993.tb06162.x 10.1128/jvi.71.8.6068-6074.1997 10.1093/nar/15.20.8125 10.1007/s00705-011-1008-x 10.1093/nar/gkv378 10.1128/MMBR.00009-09 10.1016/j.semcancer.2009.03.002 10.1371/journal.ppat.1000363 10.1128/JVI.02400-09 10.1128/jvi.65.6.3301-3308.1991 10.1038/nrmicro2992 10.1093/jnci/djp332 10.1001/jamadermatol.2014.1095 10.1128/JVI.00517-06 10.1093/nar/gkp215 10.1016/0092-8674(78)90083-1 10.1038/nrmicro2984 10.1111/jdv.13111 10.1128/CMR.05031-11 10.1371/journal.ppat.1001024 10.1099/vir.0.048462-0 10.1097/JTO.0000000000000390 10.1021/pr3005937 10.1371/journal.pone.0108947 10.3109/13550289509113966 10.1093/infdis/jiu250 10.1099/vir.0.83317-0 10.1016/j.jcv.2011.11.007 10.1099/vir.0.009159-0 10.1073/pnas.1303526110 10.1128/CVI.00438-12 10.1126/science.1152586 10.1371/journal.pone.0081078 10.1038/nrc946 10.1001/jamadermatol.2014.1116 10.1093/infdis/jiu524 10.1172/JCI46323 |
ContentType | Journal Article |
Copyright | Copyright © 2015, American Society for Microbiology. All Rights Reserved. Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2015, American Society for Microbiology. All Rights Reserved. – notice: Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1128/JVI.00911-15 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Characterization of TSPyV T Antigens |
EISSN | 1098-5514 |
EndPage | 9439 |
ExternalDocumentID | PMC4542345 26136575 10_1128_JVI_00911_15 |
Genre | Journal Article |
GroupedDBID | --- -~X 0R~ 18M 29L 2WC 39C 4.4 53G 5GY 5RE 5VS 85S AAFWJ AAGFI AAYXX ABPPZ ACGFO ACNCT ADBBV AENEX AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CITATION CS3 DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 N9A O9- OK1 P2P RHI RNS RPM RSF TR2 UPT W2D W8F WH7 WOQ YQT ~02 ~KM .55 .GJ 3O- 41~ 6TJ AAYJJ ADXHL AFFNX AI. C1A CGR CUY CVF D0S ECM EIF MVM NPM OHT VH1 X7M Y6R ZGI ZXP 7X8 5PM |
ID | FETCH-LOGICAL-c384t-132f16b2c937115a5b6ec4d62f530b00a1c3895f76b53e2e11fe5e1ba4c64d953 |
ISSN | 0022-538X |
IngestDate | Thu Aug 21 18:27:28 EDT 2025 Fri Jul 11 01:45:40 EDT 2025 Mon Jul 21 06:03:47 EDT 2025 Thu Apr 24 23:05:42 EDT 2025 Tue Jul 01 01:02:39 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Language | English |
License | Copyright © 2015, American Society for Microbiology. All Rights Reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c384t-132f16b2c937115a5b6ec4d62f530b00a1c3895f76b53e2e11fe5e1ba4c64d953 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Citation van der Meijden E, Kazem S, Dargel CA, van Vuren N, Hensbergen PJ, Feltkamp MCW. 2015. Characterization of T antigens, including middle T and alternative T, expressed by the human polyomavirus associated with trichodysplasia spinulosa. J Virol 89:9427–9439. doi:10.1128/JVI.00911-15. |
OpenAccessLink | https://jvi.asm.org/content/jvi/89/18/9427.full.pdf |
PMID | 26136575 |
PQID | 1706206625 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4542345 proquest_miscellaneous_1706206625 pubmed_primary_26136575 crossref_primary_10_1128_JVI_00911_15 crossref_citationtrail_10_1128_JVI_00911_15 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-09-01 |
PublicationDateYYYYMMDD | 2015-09-01 |
PublicationDate_xml | – month: 09 year: 2015 text: 2015-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2015 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_24_2 e_1_3_2_25_2 Kazem S (e_1_3_2_35_2) 2013; 19 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 19759150 - J Virol. 2009 Dec;83(23):12118-28 12040123 - Microbiol Mol Biol Rev. 2002 Jun;66(2):179-202 25291363 - PLoS One. 2014;9(10):e108947 20444890 - J Virol. 2010 Jul;84(14):7064-72 21562881 - Arch Virol. 2011 Sep;156(9):1627-34 25231015 - J Infect Dis. 2015 May 15;211(10):1560-5 23474680 - Nat Rev Microbiol. 2013 Apr;11(4):264-76 8223482 - EMBO J. 1993 Dec;12(12):4739-46 24943872 - JAMA Dermatol. 2014 Nov;150(11):1180-6 24795478 - J Infect Dis. 2014 Nov 15;210(10):1595-9 21841310 - J Clin Invest. 2011 Sep;121(9):3623-34 19776382 - J Natl Cancer Inst. 2009 Nov 4;101(21):1510-22 25526237 - J Thorac Oncol. 2015 Feb;10(2):360-6 23474685 - Nat Rev Microbiol. 2013 Apr;11(4):239-51 18202256 - Science. 2008 Feb 22;319(5866):1096-100 23302741 - Clin Vaccine Immunol. 2013 Mar;20(3):363-8 19264611 - J Gen Virol. 2009 May;90(Pt 5):1238-45 22196870 - J Clin Virol. 2012 Mar;53(3):225-30 3313277 - Nucleic Acids Res. 1987 Oct 26;15(20):8125-48 20686659 - PLoS Pathog. 2010;6(7):e1001024 20399955 - Adv Cancer Res. 2010;106:1-51 9223500 - J Virol. 1997 Aug;71(8):6068-74 24278381 - PLoS One. 2013;8(11):e81078 18753241 - J Gen Virol. 2008 Sep;89(Pt 9):2303-14 9222358 - J Neurovirol. 1995 Jun;1(2):195-206 25208506 - Int J Cancer. 2015 Mar 1;136(5):E290-300 19325891 - PLoS Pathog. 2009 Mar;5(3):e1000363 12181403 - N Engl J Med. 2002 Aug 15;347(7):488-96 25389794 - JAMA Dermatol. 2014 Nov;150(11):1234-6 23847207 - Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12744-9 19505649 - Semin Cancer Biol. 2009 Aug;19(4):218-28 25904630 - Nucleic Acids Res. 2015 May 26;43(10):4800-13 12459733 - Nat Rev Cancer. 2002 Dec;2(12):951-6 25766099 - J Eur Acad Dermatol Venereol. 2016 Jun;30(6):1061-2 22763635 - Clin Microbiol Rev. 2012 Jul;25(3):471-506 18812503 - Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16272-7 1709702 - J Virol. 1991 Jun;65(6):3301-8 212199 - Cell. 1978 Sep;15(1):65-77 19339519 - Nucleic Acids Res. 2009 May;37(9):e67 19721090 - Microbiol Mol Biol Rev. 2009 Sep;73(3):542-63, Table of Contents 23050552 - J Proteome Res. 2012 Dec 7;11(12):5804-14 23255626 - J Gen Virol. 2013 Mar;94(Pt 3):482-96 16775341 - J Virol. 2006 Jul;80(13):6553-8 |
References_xml | – ident: e_1_3_2_24_2 doi: 10.1002/ijc.29200 – ident: e_1_3_2_18_2 doi: 10.1016/S0065-230X(10)06001-X – ident: e_1_3_2_19_2 doi: 10.1128/MMBR.66.2.179-202.2002 – ident: e_1_3_2_32_2 doi: 10.1073/pnas.0806526105 – ident: e_1_3_2_26_2 doi: 10.1128/JVI.01336-09 – ident: e_1_3_2_9_2 doi: 10.1056/NEJMoa020439 – ident: e_1_3_2_34_2 doi: 10.1002/j.1460-2075.1993.tb06162.x – ident: e_1_3_2_31_2 doi: 10.1128/jvi.71.8.6068-6074.1997 – volume: 19 start-page: 298 year: 2013 ident: e_1_3_2_35_2 article-title: Global circulation of slowly evolving trichodysplasia spinulosa-associated polyomavirus and its adaptation to the human population through alternative T antigens publication-title: J Neurovirol – ident: e_1_3_2_45_2 doi: 10.1093/nar/15.20.8125 – ident: e_1_3_2_17_2 doi: 10.1007/s00705-011-1008-x – ident: e_1_3_2_36_2 doi: 10.1093/nar/gkv378 – ident: e_1_3_2_23_2 doi: 10.1128/MMBR.00009-09 – ident: e_1_3_2_20_2 doi: 10.1016/j.semcancer.2009.03.002 – ident: e_1_3_2_5_2 doi: 10.1371/journal.ppat.1000363 – ident: e_1_3_2_25_2 doi: 10.1128/JVI.02400-09 – ident: e_1_3_2_37_2 doi: 10.1128/jvi.65.6.3301-3308.1991 – ident: e_1_3_2_3_2 doi: 10.1038/nrmicro2992 – ident: e_1_3_2_2_2 doi: 10.1093/jnci/djp332 – ident: e_1_3_2_28_2 doi: 10.1001/jamadermatol.2014.1095 – ident: e_1_3_2_43_2 doi: 10.1128/JVI.00517-06 – ident: e_1_3_2_42_2 doi: 10.1093/nar/gkp215 – ident: e_1_3_2_38_2 doi: 10.1016/0092-8674(78)90083-1 – ident: e_1_3_2_44_2 doi: 10.1038/nrmicro2984 – ident: e_1_3_2_29_2 doi: 10.1111/jdv.13111 – ident: e_1_3_2_8_2 doi: 10.1128/CMR.05031-11 – ident: e_1_3_2_11_2 doi: 10.1371/journal.ppat.1001024 – ident: e_1_3_2_4_2 doi: 10.1099/vir.0.048462-0 – ident: e_1_3_2_15_2 doi: 10.1097/JTO.0000000000000390 – ident: e_1_3_2_41_2 doi: 10.1021/pr3005937 – ident: e_1_3_2_27_2 doi: 10.1371/journal.pone.0108947 – ident: e_1_3_2_33_2 doi: 10.3109/13550289509113966 – ident: e_1_3_2_16_2 doi: 10.1093/infdis/jiu250 – ident: e_1_3_2_40_2 doi: 10.1099/vir.0.83317-0 – ident: e_1_3_2_12_2 doi: 10.1016/j.jcv.2011.11.007 – ident: e_1_3_2_30_2 doi: 10.1099/vir.0.009159-0 – ident: e_1_3_2_39_2 doi: 10.1073/pnas.1303526110 – ident: e_1_3_2_7_2 doi: 10.1128/CVI.00438-12 – ident: e_1_3_2_10_2 doi: 10.1126/science.1152586 – ident: e_1_3_2_6_2 doi: 10.1371/journal.pone.0081078 – ident: e_1_3_2_22_2 doi: 10.1038/nrc946 – ident: e_1_3_2_13_2 doi: 10.1001/jamadermatol.2014.1116 – ident: e_1_3_2_14_2 doi: 10.1093/infdis/jiu524 – ident: e_1_3_2_21_2 doi: 10.1172/JCI46323 – reference: 23847207 - Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12744-9 – reference: 19339519 - Nucleic Acids Res. 2009 May;37(9):e67 – reference: 23255626 - J Gen Virol. 2013 Mar;94(Pt 3):482-96 – reference: 23302741 - Clin Vaccine Immunol. 2013 Mar;20(3):363-8 – reference: 12459733 - Nat Rev Cancer. 2002 Dec;2(12):951-6 – reference: 18753241 - J Gen Virol. 2008 Sep;89(Pt 9):2303-14 – reference: 12040123 - Microbiol Mol Biol Rev. 2002 Jun;66(2):179-202 – reference: 18202256 - Science. 2008 Feb 22;319(5866):1096-100 – reference: 24943872 - JAMA Dermatol. 2014 Nov;150(11):1180-6 – reference: 20399955 - Adv Cancer Res. 2010;106:1-51 – reference: 23474680 - Nat Rev Microbiol. 2013 Apr;11(4):264-76 – reference: 25291363 - PLoS One. 2014;9(10):e108947 – reference: 25904630 - Nucleic Acids Res. 2015 May 26;43(10):4800-13 – reference: 212199 - Cell. 1978 Sep;15(1):65-77 – reference: 8223482 - EMBO J. 1993 Dec;12(12):4739-46 – reference: 20686659 - PLoS Pathog. 2010;6(7):e1001024 – reference: 20444890 - J Virol. 2010 Jul;84(14):7064-72 – reference: 24278381 - PLoS One. 2013;8(11):e81078 – reference: 18812503 - Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16272-7 – reference: 19264611 - J Gen Virol. 2009 May;90(Pt 5):1238-45 – reference: 1709702 - J Virol. 1991 Jun;65(6):3301-8 – reference: 12181403 - N Engl J Med. 2002 Aug 15;347(7):488-96 – reference: 25766099 - J Eur Acad Dermatol Venereol. 2016 Jun;30(6):1061-2 – reference: 19505649 - Semin Cancer Biol. 2009 Aug;19(4):218-28 – reference: 16775341 - J Virol. 2006 Jul;80(13):6553-8 – reference: 25208506 - Int J Cancer. 2015 Mar 1;136(5):E290-300 – reference: 25231015 - J Infect Dis. 2015 May 15;211(10):1560-5 – reference: 9223500 - J Virol. 1997 Aug;71(8):6068-74 – reference: 22763635 - Clin Microbiol Rev. 2012 Jul;25(3):471-506 – reference: 9222358 - J Neurovirol. 1995 Jun;1(2):195-206 – reference: 25526237 - J Thorac Oncol. 2015 Feb;10(2):360-6 – reference: 3313277 - Nucleic Acids Res. 1987 Oct 26;15(20):8125-48 – reference: 19776382 - J Natl Cancer Inst. 2009 Nov 4;101(21):1510-22 – reference: 24795478 - J Infect Dis. 2014 Nov 15;210(10):1595-9 – reference: 21562881 - Arch Virol. 2011 Sep;156(9):1627-34 – reference: 19721090 - Microbiol Mol Biol Rev. 2009 Sep;73(3):542-63, Table of Contents – reference: 25389794 - JAMA Dermatol. 2014 Nov;150(11):1234-6 – reference: 19759150 - J Virol. 2009 Dec;83(23):12118-28 – reference: 23474685 - Nat Rev Microbiol. 2013 Apr;11(4):239-51 – reference: 21841310 - J Clin Invest. 2011 Sep;121(9):3623-34 – reference: 23050552 - J Proteome Res. 2012 Dec 7;11(12):5804-14 – reference: 22196870 - J Clin Virol. 2012 Mar;53(3):225-30 – reference: 19325891 - PLoS Pathog. 2009 Mar;5(3):e1000363 |
SSID | ssj0014464 |
Score | 2.337937 |
Snippet | The polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by partially... UNLABELLEDThe polyomavirus tumor (T) antigens play crucial roles in viral replication, transcription, and cellular transformation. They are encoded by... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 9427 |
SubjectTerms | Alternative Splicing - physiology Antigens, Viral, Tumor - biosynthesis Antigens, Viral, Tumor - genetics Gene Expression Regulation, Viral - physiology Genome and Regulation of Viral Gene Expression HEK293 Cells HeLa Cells Humans Polyomavirus - genetics Polyomavirus - metabolism |
Title | Characterization of T Antigens, Including Middle T and Alternative T, Expressed by the Human Polyomavirus Associated with Trichodysplasia Spinulosa |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26136575 https://www.proquest.com/docview/1706206625 https://pubmed.ncbi.nlm.nih.gov/PMC4542345 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb5swELeiTpP2Mu3_un_ypO0ppSvGhuQx6jq1nVJNKq3yhjAxLROFKAnVkq-xr7UPtTsbHJK2UrcXFGFjktyPu_Nx9ztCPiUx88Hq7jkJc7nDVTB2-uMUsywEV0r5PNWMN8MT__CMH4_EqNP508paquZyN1neWlfyP1KFcyBXrJL9B8naReEEfAb5whEkDMd7yXjfsi0vrecXIh8AUmw2j39e6bqVoY5EwDBGygd5HQe8hjNaHf7SCbG1OwrQMcH9H2W-KK_i62xazawkm4T1EFToZTlezCa6FLN7OsmKKi9n8R0OL1bUtWP4WDmFTBZDlf2std9Bvnq3FC-VxuppFl_FJjW8ialfmNQCQ4yQFXF3sNte9LyamuVOGsr_OqzhCpu31S4zAG08MobKaGckP0UXr62-TQeiBqa9ljLuc0M7UBv2Pje0STeNBsNCiOPzo11wODHDT6yMY5MQsGEzbSaj3kOxXgRXR_rqCBkPHjDYtGA_ja9H3-07Ldh484a7Hn9YU4bBel_a9153kG7sejaTd1veUPiEPK6lSgcGk09JRxXPyEPT2HTxnPzeRCYtUxrSBpk71OKSGlzCIOCStnBJwx1qUUnlggIqqUYlbaOSrlBJEZV0A5XUovIFOft2EO4fOnX7DyfxenzuuB5LXV-yBCkbXREL6auEj32WCm8PrEXswry-SANfCk8x5bqpEsqVMU98Pu4L7yXZKspCvSZUBBL73QcplwFPXCljCdsAz1NjmXhBL90m3eY_j5KaGx9btOTRbfLdJp_t7InhhLlj3sdGfBEobXwTFxeqrGYRclZhHwUGc14ZcdqVmI-ZpwGMBGuCthOQEH59pMguNTE8F7A54uLNPb_fW_Jo9eS9I1vzaaXeg4s9lx80cv8Cj5rWEg |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+T+Antigens%2C+Including+Middle+T+and+Alternative+T%2C+Expressed+by+the+Human+Polyomavirus+Associated+with+Trichodysplasia+Spinulosa&rft.jtitle=Journal+of+virology&rft.au=van+der+Meijden%2C+Els&rft.au=Kazem%2C+Siamaque&rft.au=Dargel%2C+Christina+A.&rft.au=van+Vuren%2C+Nick&rft.date=2015-09-01&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=89&rft.issue=18&rft.spage=9427&rft.epage=9439&rft_id=info:doi/10.1128%2FJVI.00911-15&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JVI_00911_15 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |